% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

  • thirdmeinvestor thirdmeinvestor Nov 19, 2010 1:36 PM Flag

    ThinkEquity was not alone (ALNY) Ticker Alert for In Play

    19-Nov-10 10:32 ET

    Alnylam Pharma shares oversold on Roche and Novartis moves - Rodman and Renshaw (10.0 -0.16)

    Rodman and Renshaw says ALNY shares are oversold on Roche and Novartis moves and they view Alnylam's fundamentals as strong as ever and expect shares to recover significantly, providing considerable returns to investors that step in at today's levels. They note ALNY shares have come down more than 30% since late September when Novartis (NVS) decided to not exercise its option for access to Alnylam's license for all therapeutics areas in exchange for $100 mln, followed by Roche's (RHHBY) decision this week to exit the RNAi space.
    While they don't see either move as a net positive for Alnylam, they see the stock as attractive at these levels.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Nice for these Bull-Side analyst to come out and defend the stock after they got all thier clients to invest in this Dog at much higher prices.

      I mean really are they puting any thing on the line (its a good value @$10) given its got $8.50 in cash on the B.S. What a bunch of stradruals.

      Its still DEAD MONEY

65.59-1.92(-2.84%)Feb 5 4:00 PMEST